What Johnson & Johnson and Eli Lilly are saying about Trump’s pharmaceutical tariffs, and Dexcom scores FDA approval for its glucose monitoring system.
Trump doubled down on plans to soon impose "major" pharmaceutical tariffs, while early stage startups dominated digital health funding deals in first quarter.
Pete Hynes, 40, went for a 'lie down' one Saturday morning in December 2022 after suffering a sudden earache, which he put down to a cold that had struck the rest of the family.